Igen bioterror defense
This article was originally published in The Gray Sheet
Executive Summary
Origen biothreat environmental detection product contract with Department of Defense's Joint Program Executive Office for Chemical & Biological Defense will bring in $23 mil. over four years and double the firm's biodefense revenues over the next year, Igen says. During FDA's April Science Forum, PEO-CBD said its initial protocol likely would be a Roche Taqman PCR-type device (1"The Gray Sheet" May 5, 2003, p. 10)...